These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29263306)

  • 1. Computational analysis of antibody dynamics identifies recent HIV-1 infection.
    Seaton KE; Vandergrift NA; Deal AW; Rountree W; Bainbridge J; Grebe E; Anderson DA; Sawant S; Shen X; Yates NL; Denny TN; Liao HX; Haynes BF; Robb ML; Parkin N; Santos BR; Garrett N; Price MA; Naniche D; Duerr AC; ; Keating S; Hampton D; Facente S; Marson K; Welte A; Pilcher CD; Cohen MS; Tomaras GD
    JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
    Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
    PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short Communication: Heightened HIV Antibody Responses in Postpartum Women as Exemplified by Recent Infection Assays: Implications for Incidence Estimates.
    Hargrove JW; van Schalkwyk C; Humphrey JH; Mutasa K; Ntozini R; Owen SM; Masciotra S; Parekh BS; Duong YT; Dobbs T; Kilmarx PH; Gonese E
    AIDS Res Hum Retroviruses; 2017 Sep; 33(9):902-904. PubMed ID: 28443672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Performance of Three Biomarker Assays for Recent HIV Infection Using a Well-Characterized HIV-1 Subtype C Incidence Cohort.
    Gonese E; Kilmarx PH; van Schalkwyk C; Grebe E; Mutasa K; Ntozini R; Parekh B; Dobbs T; Duong Pottinger Y; Masciotra S; Owen M; Nachega JB; van Zyl G; Hargrove JW
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):615-627. PubMed ID: 30938164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx.
    Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jõgeda EL; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I;
    PLoS One; 2019; 14(5):e0217048. PubMed ID: 31125356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection.
    Yates NL; Lucas JT; Nolen TL; Vandergrift NA; Soderberg KA; Seaton KE; Denny TN; Haynes BF; Cohen MS; Tomaras GD
    AIDS; 2011 Nov; 25(17):2089-97. PubMed ID: 21832938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High avidity anti-integrase antibodies discriminate recent and non-recent HIV infection: Implications for HIV incidence assay.
    Rikhtegaran Tehrani Z; Azadmanesh K; Mostafavi E; Gharibzadeh S; Soori S; Azizi M; Khabiri A
    J Virol Methods; 2018 Mar; 253():5-10. PubMed ID: 29248529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential maturation of avidity of IgG antibodies to gp41, p24 and p17 following infection with HIV-1.
    Thomas HI; Wilson S; O'Toole CM; Lister CM; Saeed AM; Watkins RP; Morgan-Capner P
    Clin Exp Immunol; 1996 Feb; 103(2):185-91. PubMed ID: 8565298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.
    Parekh BS; Pau CP; Kennedy MS; Dobbs TL; McDougal JS
    AIDS Res Hum Retroviruses; 2001 Jan; 17(2):137-46. PubMed ID: 11177393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 Incidence.
    Gao Z; Yan H; Feng X; Wu L; Qiu M; Xing W; Zhang G; Zhang Z; Jiang Y
    PLoS One; 2016; 11(8):e0161183. PubMed ID: 27513563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein.
    Wei X; Liu X; Dobbs T; Kuehl D; Nkengasong JN; Hu DJ; Parekh BS
    AIDS Res Hum Retroviruses; 2010 Jan; 26(1):61-71. PubMed ID: 20063992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array.
    Gallerano D; Ndlovu P; Makupe I; Focke-Tejkl M; Fauland K; Wollmann E; Puchhammer-Stöckl E; Keller W; Sibanda E; Valenta R
    PLoS One; 2015; 10(2):e0117204. PubMed ID: 25658330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence.
    Keating SM; Kassanjee R; Lebedeva M; Facente SN; MacArthur JC; Grebe E; Murphy G; Welte A; Martin JN; Little S; Price MA; Kallas EG; Busch MP; Pilcher CD
    J Acquir Immune Defic Syndr; 2016 Dec; 73(5):581-588. PubMed ID: 27509247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating HIV incidence in the Akwa Ibom AIDS indicator survey (AKAIS), Nigeria using the limiting antigen avidity recency assay.
    Negedu-Momoh OR; Balogun O; Dafa I; Etuk A; Oladele EA; Adedokun O; James E; Pandey SR; Khamofu H; Badru T; Robinson J; Mastro TD; Torpey K
    J Int AIDS Soc; 2021 Feb; 24(2):e25669. PubMed ID: 33619853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
    Duong YT; Kassanjee R; Welte A; Morgan M; De A; Dobbs T; Rottinghaus E; Nkengasong J; Curlin ME; Kittinunvorakoon C; Raengsakulrach B; Martin M; Choopanya K; Vanichseni S; Jiang Y; Qiu M; Yu H; Hao Y; Shah N; Le LV; Kim AA; Nguyen TA; Ampofo W; Parekh BS
    PLoS One; 2015; 10(2):e0114947. PubMed ID: 25710171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
    Sempa JB; Welte A; Busch MP; Hall J; Hampton D; Facente SN; Keating SM; Marson K; Parkin N; Pilcher CD; Murphy G; Grebe E;
    PLoS One; 2019; 14(7):e0220345. PubMed ID: 31348809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of HIV-1-specific antibody responses.
    Curtis KA; Kennedy MS; Owen SM
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1099-105. PubMed ID: 25314631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.